Clinical Trial Update: 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2a clinical trial of 99mTc-rhAnnexin V-128 in rheumatoid arthritis and ankylosing spondylitis; trial terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Rheumatoid Arthritis

Drugs mentioned

• 99mTc-rhAnnexin V-128 (rhAnnexin V-128)

Snippet

Sponsor: Advanced Accelerator Applications | Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-06-09